Our Expertise

Cost-effectiveness assessment for drug to be listed on the hospital ‘expensive drug list’ Cost-effectiveness assessment for an orphan drug Diabetes (type 1) Diaper dermatitis complicated by candidiasis in infants Heart failure Herpes zoster vaccine HPV vaccine Metabolic syndrome Metastatic soft-tissue sarcoma… Read More

Anthracycline extravasation Breakthrough cancer pain Breast cancer Diabetes (type 2) Epilepsy Gastric cancer Head and neck cancer Hepatitis B HIV Homocystinuria Infertility Iron overload Kidney failure Lung cancer (non-small cell) Parkinson’s disease Psoriatic arthritis Secondary hyperparathyroidism in end stage renal disease Ulcerative colitis… Read More

We have a vast amount of experience in this area including the creation of global/core value dossiers, AMCP dossiers, payer value/evidence dossiers and reimbursement dossiers. Actinic keratosis Anaesthesia Ankylosing spondylitis Aortic stenosis Asthma Atopic dermatitis Attention deficit hyperactivity disorder (ADHD) Breast cancer Chronic obstructive pulmonary disease (COPD) Colonoscopy Crohn’s disease… Read More

Bone healing Chronic pain in malignant cancer Epilepsy Fatigue and functioning in fibromyalgia Female hypoactive sexual desire disorder Fibromyalgia Heart failure with preserved ejection fraction Goitre Inhaled insulin in type 2 diabetes Opioid addiction Rheumatoid arthritis Review of a protocol and protocol amendment for a Phase II gastroparesis study which… Read More

Allergic rhinitis Chronic obstructive pulmonary disease Chronic pain Constipation predominant irritable bowel syndrome Crohn’s disease End stage renal disease patients on haemodialysis Epilepsy Epoietin alfa in chronic kidney disease Erythematous rosacea Eyelash satisfaction questionnaire Facial wrinkling Functional digestive disorders (post-prandial distress syndrome) Glioblastoma Heart failure Hereditary angioedema Hereditary hemochromatosis Hunter’s… Read More

Diabetic foot ulcers Diabetic macular oedema Diarrhoea-predominant irritable bowel syndrome Dysmenorrhea Epilepsy Epoietin alfa in chronic kidney disease Functional digestive disorders (post-prandial distress syndrome) Hereditary angioedema Hypogonadism Major depressive disorder Pain Pulmonary arterial hypertension Retinal vein occlusion Rheumatoid arthritis… Read More

We have extensive experience in modelling across a wide range of indications – our model experience includes budget impact models, cost effectiveness models, scenario models, cost calculator models, value-based pricing models, cost offset models, and cost utility models. Our experience is vast in this area and models have been developed… Read More

Addiction Interviews and Rasch analysis in opioid addiction Allergic conditions Development of a COA strategy to measure treatment side effects for peanut allergy treatments Autoimmune diseases Assessing utility for flares in systemic lupus erythematosus in the UK, France, Spain, Australia and Canada, including training and managing local interviewing agencies and… Read More

Value communication support in acute otitis media associated with respiratory syncytial virus (RSV) Diary of a caregiver validation for ear infection using the standard methodology Training and manuscripts on the acute otitis media caregiver diary Quality of life impact of otitis media and associated productivity loss in Malaysia and South… Read More

Burden of disease literature review on typhoid in the UK and Ireland… Read More

Burden of disease literature review on rabies in the UK and Ireland… Read More

Burden of disease literature review on polio in the UK and Ireland… Read More

Burden of disease literature review on tetanus in the UK and Ireland… Read More